Entropy Technologies’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
Entropy Technologies's NVAX Position: Q3 2026 in Review
Entropy Technologies opened a new position in Novavax (NVAX) in Q3 2026: 97,369 shares worth $1.05M. The stake represents 0.03% of the portfolio and ranks #586 among its holdings. This is a return to the name: Entropy Technologies previously reported a position in NVAX as recently as Q1 2025.
Entropy Technologies first reported a position in NVAX in Q3 2024 and has held it in 3 quarters since. 260 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.
- Entropy Technologies held 97,369 shares of Novavax worth $1.05M as of Q3 2026.
- Novavax was a new Entropy Technologies position in Q3 2026.
- Novavax made up 0.03% of Entropy Technologies's portfolio in Q3 2026, its #586 holding.
- Entropy Technologies first reported a position in Novavax in Q3 2024 and has held it in 3 quarters since.
- 260 funds tracked by Wall St. Rank held Novavax as of Q3 2026.
Based on Entropy Technologies's 13F filing for Q3 2026, filed 13 Nov 2026.